Created at Source Raw Value Validated value
April 8, 2022, 9:30 p.m. usa

inclusion criteria: (i) hospitalised (ii) viral pneumonia syndrome in general, viral pneumonia should be suspected when a patient presents with: typical symptoms (e.g. influenza-like illness with fever and muscle pain, or respiratory illness with cough and shortness of breath); and compatible chest x-ray findings (consolidation or ground-glass shadowing); and alternative causes have been considered unlikely or excluded (e.g. heart failure, bacterial pneumonia). however, the diagnosis remains a clinical one based on the opinion of the managing doctor. (iii) sars-cov-2 infection (clinically suspected or laboratory confirmed) (iv) no medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial

inclusion criteria: (i) hospitalised (ii) viral pneumonia syndrome in general, viral pneumonia should be suspected when a patient presents with: typical symptoms (e.g. influenza-like illness with fever and muscle pain, or respiratory illness with cough and shortness of breath); and compatible chest x-ray findings (consolidation or ground-glass shadowing); and alternative causes have been considered unlikely or excluded (e.g. heart failure, bacterial pneumonia). however, the diagnosis remains a clinical one based on the opinion of the managing doctor. (iii) sars-cov-2 infection (clinically suspected or laboratory confirmed) (iv) no medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: - (i) hospitalised - (ii) sars-cov-2 infection (clinically suspected or laboratory confirmed) - (iii) no medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial

inclusion criteria: - (i) hospitalised - (ii) sars-cov-2 infection (clinically suspected or laboratory confirmed) - (iii) no medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial